SHL Telemedicine Ltd. (NASDAQ:SHLT) Sees Significant Decrease in Short Interest

SHL Telemedicine Ltd. (NASDAQ:SHLT) saw a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 1,300 shares, a decrease of 50.0% from the March 31st total of 2,600 shares. Based on an average trading volume of 3,800 shares, the short-interest ratio is presently 0.3 days.

SHL Telemedicine Stock Performance

Shares of NASDAQ:SHLT traded up $0.34 during trading on Friday, reaching $5.55. The company had a trading volume of 471 shares, compared to its average volume of 3,766. The firm’s fifty day moving average is $5.98 and its 200 day moving average is $7.63. SHL Telemedicine has a twelve month low of $4.86 and a twelve month high of $12.75. The company has a current ratio of 2.30, a quick ratio of 2.10 and a debt-to-equity ratio of 0.20.

Wall Street Analyst Weigh In

Separately, Litchfield Hills Research reaffirmed a “buy” rating and issued a $11.00 price target on shares of SHL Telemedicine in a research note on Thursday, March 14th.

SHL Telemedicine Company Profile

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center.